![]() |
Medical Industry FeatureAuthor: ReachMD
Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry. Language: en Genres: Health & Fitness, Medicine, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Severe Active ANCA-Associated Vasculitis (GPA/MPA): Defining Disease
Sunday, 15 November, 2026
Host: Zach Wallace, MD Guest: Anisha Dua, MD, MPH Guest: Frank Cortazar, MD Treatment decisions in ANCA-associated vasculitis, granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are often influenced by disease severity.1 However, theres no consensus definition of severe active GPA or MPA.2 Having a consistent framework matters because it gives clinicians a shared way to think about disease severity2 and identify patients who may require urgent evaluation, closer monitoring, and other treatment options3—while still leaving room for clinical judgement. Given that importance, Dr Zach Wallace speaks with Drs Anisha Dua and Frank Cortazar about a validated definition of severe active GPA and MPA and how it may be applicable in clinical practice. Dr Dua is the Director of the Northwestern Vasculitis Center and a Professor of Medicine in the Division of Rheumatology at Northwestern University Feinberg School of Medicine in Chicago, and Dr Cortazar is the Director of the New York Nephrology Vasculitis and Glomerular Center in Albany, New York. References: Chung SA, et al. Arthritis Rheumatol. 2021;73:1366–1383. Hellmich B, et al. Ann Rheum Dis. 2024;83:30–47. Chevet B, et al. Rheumatology (Oxford). 2023;62:1787–1803.











